Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$126.46 - $235.05 $115,078 - $213,895
-910 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$225.82 - $368.51 $27,775 - $45,326
123 Added 15.63%
910 $231,000
Q3 2021

Nov 01, 2021

SELL
$221.9 - $484.47 $68,345 - $149,216
-308 Reduced 28.13%
787 $303,000
Q2 2021

Jul 22, 2021

BUY
$129.91 - $234.98 $142,251 - $257,303
1,095 New
1,095 $257,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sage Mountain Advisors LLC Portfolio

Follow Sage Mountain Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Mountain Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Mountain Advisors LLC with notifications on news.